No abstract available
MeSH terms
-
Adenine / analogs & derivatives
-
Adenine / therapeutic use
-
Adult
-
Alanine
-
Anti-HIV Agents / therapeutic use
-
Antiviral Agents / therapeutic use
-
Betacoronavirus
-
COVID-19
-
COVID-19 Drug Treatment
-
Coronavirus Infections / complications*
-
Coronavirus Infections / drug therapy
-
Coronavirus Infections / physiopathology
-
Dideoxynucleosides / therapeutic use
-
Drug Combinations
-
Emtricitabine
-
Female
-
HIV Infections / complications*
-
HIV Infections / drug therapy
-
Heterocyclic Compounds, 3-Ring / therapeutic use
-
Heterocyclic Compounds, 4 or More Rings / therapeutic use
-
Humans
-
Lamivudine / therapeutic use
-
Lopinavir / therapeutic use
-
Male
-
Middle Aged
-
Oxazines
-
Pandemics
-
Piperazines
-
Pneumonia, Viral / complications*
-
Pneumonia, Viral / drug therapy
-
Pneumonia, Viral / physiopathology
-
Pyridones
-
Ritonavir / therapeutic use
-
SARS-CoV-2
-
Tenofovir / therapeutic use
-
Transgender Persons*
Substances
-
Anti-HIV Agents
-
Antiviral Agents
-
Dideoxynucleosides
-
Drug Combinations
-
Heterocyclic Compounds, 3-Ring
-
Heterocyclic Compounds, 4 or More Rings
-
Oxazines
-
Piperazines
-
Pyridones
-
bictegravir, emtricitabine, tenofovir alafenamide, drug combination
-
lopinavir-ritonavir drug combination
-
Lopinavir
-
Lamivudine
-
Tenofovir
-
dolutegravir
-
Emtricitabine
-
Adenine
-
Ritonavir
-
Alanine
-
abacavir